Teijin Pharma Limited;National University Corporation Tottori University
发明人:
申请号：
EP13740913.2
公开号：
EP2808018B1
申请日:
2013.01.25
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The purpose of the present invention is to provide a novel therapeutic agent or a novel prophylactic agent for diseases associated with abnormal glucose metabolism. The present invention is a therapeutic agent or a prophylactic agent for diseases associated with abnormal glucose metabolism, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
